Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of LY333531 on Vascular and Neural Functions

This study has been completed.
Sponsor:
Collaborator:
Joslin Diabetes Center
Information provided by:
Chromaderm, Inc.
ClinicalTrials.gov Identifier:
NCT00482976
First received: June 4, 2007
Last updated: July 25, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2005
  Estimated Primary Completion Date: No date given